Acutus Medical announced that it received FDA clearance for its AcQCross family of universal transseptal crossing devices. Carlsbad, Calif.-based Acutus touts the AcQCross system as the first and only transseptal puncture system specifically engineered to pair and mate seamlessly with Acutus’ suite of sheaths, as well as with sheaths sold by other manufacturers, according to […]
Acutus Medical
Acutus Medical names new chief financial officer
Acutus Medical (Nasdaq: AFIB) today announced that it appointed David Roman as its CFO, effective March 1. Founded in 2011, Carlsbad, Calif.–based Acutus Medical boasts a portfolio of electrophysiology products that includes catheter-based treatments for cardiac arrhythmias. Roman has more than 15 years of experience in the medical technology industry. Prior to joining the company, […]
Acutus appoints chief translational science officer
Acutus Medical (NSDQ:AFIB) announced that it appointed Dr. Steven Mickelsen as its chief translational science officer. Carlsbad, Calif.-base Acutus, which develops cardiac mapping technology, said in a news release that Mickelsen is set to guide the company’s vision to deliver the “most advanced electrophysiology therapeutic solutions on the market for physicians and their patients.” Mickelsen […]
MedTech 100 roundup: Another high as stocks tick up
For the third consecutive week, stocks in the medtech industry reached heights not yet seen since the COVID-19 pandemic began. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 89.65 points at the end of last week (Aug. 7). Overall, medtech stocks saw a 0.72% increase from […]
Acutus Medical launches IPO on Nasdaq
Cardiac mapping technology developer Acutus Medical announced that it priced its initial public offering on the Nasdaq market. The Carlsbad, Calif.-based company is offering 8,823,529 shares of its common stock at $18 per share, with gross proceeds expected to come in at approximately $158.8 million. Acutus Medical’s shares are expected to begin trading today (Aug.6, […]
Acutus Medical, Biotronik ink deal
Acutus Medical and Biotronik have announced that they will collaborate on electrophysiology, mapping, ablation and accessory products across certain markets. The products involved in the collaboration center around the treatment of cardiac arrhythmias in markets that include Europe and Asia, according to a news release. The partnership centers on Acutus’ AcQMap system, which Acutus touts […]
These young medtech companies raised the most money in 2019
Medical device industry insiders may very well remember 2019 as the year that IPOs came back — but another sign that the U.S. economy has left the Great Recession far behind. Among the top investment deals in the space, half involved public offerings, according to the MoneyTree report from PricewaterhouseCoopers (PwC) and CB Insights. Total investments […]
Acutus, Innovative Health ink EP deal
Acutus Medical and Innovative Health this week announced a partnership that will combine the companies’ portfolios of electrophysiology products. The companies plan to work together to gain clearances, market products and rein in per-procedure costs while using hospital money for emerging technologies, according to a news release. Recognizing the constraints that hospitals and health systems […]
Acutus Medical reels in $170m
Acutus Medical said today that it pulled down $170 million in financing from its Series D offering and a new credit line for the cardiac mapping technology it developed. In addition to its AcQMap tech to aid in ablation treatment of arrhythmias, Carlsbad, Calif.-based Acutus makes a line of vascular access products. It’s latest financing […]
Acutus Medical acquires Rhythm Xience
Acutus Medical said today that it agreed to acquire Rhythm Xience for an undisclosed amount and inked deals with a trio of new partners. Eden Prairie, Minn.-based Rhythm Xience makes a line of transseptal crossing and steerable introducer systems including the Flextra, Guider and Lancer devices, which are all 510(k)-cleared by the FDA. “At Acutus, we […]
Acutus Medical wins expanded CE Mark, FDA nod for AcQMap revisions
Acutus Medical said today it won expanded CE Mark approval in the European Union for its AcQMap contact mapping software and FDA clearance in the U.S. for its second-gen AcQMap system. Carlsbad, Calif.-based Acutus Medical’s AcQMap system is designed to detect and display standard voltage-based and higher resolution charge-source maps, and is able to generate real-time, 3D […]